Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q2 FY26 results · Jul–Sep 2025
Wockhardt reported revenue from operations of ₹782.00 crore (down 3.3% from Q2 FY25) and net profit of ₹82.00 crore for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 782.00 | 809.00 | −3.3% | 738.00 | +6.0% |
| Other income | 21.00 | 9.00 | +133.3% | 20.00 | +5.0% |
| Total income | 803.00 | 818.00 | −1.8% | 758.00 | +5.9% |
| Profit before tax | 91.00 | (9.00) | Turned profit | (109.00) | Turned profit |
| Net profit for the period | 82.00 | (16.00) | Turned profit | (108.00) | Turned profit |
| Attributable to shareholders of the company | 78.00 | (22.00) | Turned profit | (90.00) | Turned profit |
| EPS, basic (₹) | 4.81 | (1.47) | Turned profit | (5.53) | Turned profit |
| Net margin (%) | 10.5 | -2.0 | -14.6 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 380.00 | 370.00 | +2.7% | 413.00 | −8.0% |
| Other income | 30.00 | 11.00 | +172.7% | 25.00 | +20.0% |
| Total income | 410.00 | 381.00 | +7.6% | 438.00 | −6.4% |
| Profit before tax | 54.00 | (36.00) | Turned profit | 69.00 | −21.7% |
| Net profit for the period | 54.00 | (36.00) | Turned profit | 69.00 | −21.7% |
| EPS, basic (₹) | 3.26 | (2.34) | Turned profit | 4.25 | −23.3% |
| Net margin (%) | 14.2 | -9.7 | 16.7 |
Consolidated
- Filed with BSE
- 03 Nov 2025, 16:51 IST
- Board meeting
- 03 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Nov 2025, 16:51 IST
- Board meeting
- 03 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE